Fortress Biotech (NASDAQ: FBIO) reported Q2 EPS of ($0.07), $0.16 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $17.39 million versus the consensus estimate of $15.46 million.

For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.